Phase 2 Clinical Trial Evaluates Bremelanotide In Pre- And Post-Menopausal Female Sexual Dysfunction Patients
Thu, 21 Dec 2006 08:00 AM EST
... Palatin Technologies, Inc. (Amex: PTN) and King Pharmaceuticals, Inc. (NYSE: KG) announced today that the companies have completed enrollment in the pre-menopausal cohort of a Phase 2 "at-home" clinical trial evaluating bremelanotide in pre- and post-menopausal patients experiencing female sexual dysfunction (FSD). [click link for full article] ...
Related Topics
- Clinical Trials
- Sexual Dysfunction
- Female Sexual Dysfunction
- Sexual Health
- Erectile Dysfunction
- Rape
- Sexual Harassment
- What Your Female Patients Want to Know About Bladder Control
- Pre/Post-op
- Sexual Violence
- Depression
- Post Traumatic Stress Disorder
- Menopause
- Pharmacology
- Autonomic Dysfunction
- Trastuzumab
- Reproductive Health
- Psychopharmacology
- Sexual Health Issues
- Child Sexual Abuse

Not Signed In -


